Resistance mechanisms of EGFR tyrosine kinase inhibitors, in EGFR exon 20 insertion-mutant lung cancer. Park S, Park S, Kim TM, Kim S, et al. Eur J Cancer 2024;208:114206.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Park S, Park S, Kim TM, Kim S, et al. Resistance mechanisms of EGFR tyrosine kinase inhibitors, in EGFR exon 20 insertion-mutant lung cancer. Eur J Cancer 2024;208:114206.
PMID: 38981315